Publication date: Jan 02, 2025
To explore the impact of the SARS-CoV-2/COVID-19 pandemic on the diagnosis, management and patient journey for children and young people with a newly diagnosed brain tumour in the UK. Exploratory qualitative study focused on patient journeys from multiple perspectives, conducted as part of a wider mixed-methods study. Three paediatric oncology tertiary centres in the UK. 10 children and young people with brain tumours (n=6 females, n=4 males), 20 caregivers (n=16 females, n=4 males) and 16 stakeholders (specialist nurses, consultant neurosurgeons and oncologists, and representatives from brain tumour charities) were interviewed between January 2022 and June 2023. The paper incorporates multiple perspectives, including those of children and young people, parents/caregivers, clinical staff and charity representatives, to explore the patient journey. Five themes describe the journey for new patients with paediatric brain tumour during the pandemic, focusing on (1) challenges getting into the healthcare system, (2) managing as a family during restrictions imposed by the pandemic, (3) complexities of building a cohesive and supportive healthcare team, (4) difficulties caregivers experienced in accessing practical and emotional support in hospital and (5) ongoing difficulties experienced by families in the community. Findings from this study offer practical insights from children, parents/caregivers and relevant stakeholders to improve the healthcare system during future disruptions. Overall, this study not only sheds light on the challenges faced by families during the pandemic but also provides suggestions for improving healthcare services to ensure a more comprehensive and effective response in times of crisis.
Open Access PDF
| Concepts | Keywords |
|---|---|
| 4males | COVID-19 |
| Neurosurgeons | Health Services |
| Nurses | Paediatric oncology |
| Pandemic | PAEDIATRICS |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 pandemic |
| drug | DRUGBANK | Etoperidone |
| disease | MESH | morbidity |
| disease | MESH | infection |
| disease | MESH | death |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | emergency |
| disease | MESH | cancers |
| disease | IDO | process |
| disease | MESH | glioma |
| pathway | KEGG | Glioma |
| disease | MESH | ependymoma |
| disease | MESH | craniopharyngioma |
| disease | MESH | carcinomas |
| disease | MESH | visual impairment |
| disease | MESH | uncertainty |
| disease | MESH | confusion |
| disease | MESH | anxiety |
| disease | MESH | panic attacks |
| disease | MESH | privacy |
| disease | IDO | role |
| pathway | REACTOME | Translation |
| disease | MESH | brain tumors |
| disease | IDO | symptom |
| disease | IDO | blood |
| disease | MESH | central nervous system tumors |